Switch to:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Other Long-Term Assets
$1,479 Mil (As of Sep. 2014)

Teva Pharmaceutical Industries Ltd's other long-term assets for the quarter that ended in Sep. 2014 was $1,479 Mil.

Teva Pharmaceutical Industries Ltd's quarterly other long-term assets declined from Mar. 2014 ($1,470 Mil) to Jun. 2014 ($1,469 Mil) but then increased from Jun. 2014 ($1,469 Mil) to Sep. 2014 ($1,479 Mil).

Teva Pharmaceutical Industries Ltd's annual other long-term assets increased from Dec. 2011 ($1,133 Mil) to Dec. 2012 ($1,338 Mil) and increased from Dec. 2012 ($1,338 Mil) to Dec. 2013 ($1,696 Mil).


Assets are presented on the balance sheet in order of their liquidity. If a company expects to sell or otherwise recognize the economic value of an asset within one year, the asset is generally classified as a current asset on the balance sheet. Cash on hand is a common current asset.

A long-term asset is an asset that a company expects to sell or otherwise recognize the economic value of after more than one year. Property, plant and equipment, and intangible assets are common long-term assets. Except those two items and current assets, the others we treated as "Other Long Term Assets".

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Teva Pharmaceutical Industries Ltd Annual Data

Other Long-Term Assets 8434106137129016767701,1331,3381,696

Teva Pharmaceutical Industries Ltd Quarterly Data

Other Long-Term Assets 1,2271,3561,3381,3851,3991,5321,6961,4701,4691,479
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial